Join Transform 2021 this July 12-16. Register for the AI event of the year.


Neurotechnology startup Rythm, based in France, has raised $11 million in funding and announced a new partnership with France’s biomedical research institute for research into sleep conditions.

The new round of funding comes from biotech investor and entrepreneur Dr Laurent Alexandre, telecoms investor Xavier Niel, and public grants.

The funds will be used to further develop its Dreem headband, a wearable device with sensors that collects brain signals during the night and monitors the wearer’s sleep quality. Future potential uses include virtual reality, education, and improving understanding of the human brain. The startup has also built a team of staff on both the neuroscience and hardware ends of things.

Rythm is now the world’s largest neurotechnology company, according to CEO Hugo Mercier. “Beyond Dreem, we’re working with leading academic experts and our talented team of engineers and scientists to develop a multitude of possibilities for further products to solve every day human problems, in areas like sleep quality, learning, entertainment, and various others that we haven’t even dreamed of yet. For us, this is just the beginning,” he said.

Rythm has partnered with the French Armed Forces Biomedical Research Institute and researchers at Paris Descartes University to conduct clinical trials using the Dreem headband to track and monitor sleep loss and unconventional sleep routines.

“What Rythm has developed with Dreem has massive potential, particularly when you consider the importance of sleep,” said Alexandre. “Their work, to impact and better understand the human brain, starting with sleep, is exciting and at the forefront of the next frontier. The intersection of neuroscience and advanced technology is something that I wanted to be a part of.”

Rythm is headquartered in Paris with an office in San Francisco.

This post first appeared on Tech.eu.

VentureBeat

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member